Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Platelet Disorders and VWD

Tuesday, December 9, 2008: 1:00 PM-2:30 PM
301 - South (Moscone Center)
Moderators:
Laura Noé and Soochong Kim, PhD
1:00 PM
Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G Protein Signaling 2 (RGS2)

Laura Noé1*, Kathleen Freson1*, Elke Giets1*, Chantal Thijs1*, Christine Wittevrongel1* and Christel Van Geet, MD, PhD2

1Center for Molecular and Vascular Biology, KULeuven, Leuven, Belgium
2Dept. of Hematology, Pediatrics, UZ Gasthuisberg Leuven, Leuven, Belgium

1:15 PM
Negative Regulation of Gq-Mediated Pathways in Platelets by G12/13 Pathways through Fyn Kinase

Soochong Kim, DVM, PhD* and Satya P. Kunapuli, Ph.D.

Physiology, Temple University School of Medicine, Philadelphia, PA

1:30 PM
RUNX1/CBFA2 Regulates Myosin Light Chain 9 (MYL9) in Megakaryocytic Cells: Decreased MYL9 Expression in Human RUNX1 Haplodeficiency

Gauthami S Jalagadugula, Ph.D1*, Gurpreet Kaur, Ph.D1*, Guangfen Mao, MD1*, Danny Dhanasekaran, Ph.D2* and A. Koneti Rao, MD1*

1Thrombosis Research Center and Department of Medicine, Temple University School of Medicine, Philadelphia, PA
2Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Phialdelphia, PA

1:45 PM
High Mortality in Mice with Platelets Expressing Integrin αIIbβ3 Locked-in Its High Affinity State

David A. Wilcox, PhD1, Juan Fang, MD1*, Paula North, MD, PhD2*, Paquita Nurden, MD3, Alan T. Nurden, PhD3 and Nathalie Valentin, PhD4*

1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
2Department of Pathology, Medical College of Wisconsin
3CRPP/PTIB, Pessac, France
4Laboratoire d'Immunologie, Laboratoire de thérapie génique, INSERM U649, Nantes, France

2:00 PM
Recombinant Protein Infusion and Hydrodynamic Plasmid Delivery Strategies Provide Distinct and Complementary Approaches to the Characterization of Variant Forms of Von Willeband Factor (VWF) in VWF Knockout Mice

Cynthia M. Pruss, BSc*, Carol A. Hegadorn*, Andrea Labelle*, Erin Burnett*, Mia Golder* and David Lillicrap, MD

Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada

2:15 PM
Quebec Platelet Disorder Is Caused by a Cis-Acting Mutation near the Plasminogen Activator Gene (PLAU) That Increases PLAU Transcription by Megakaryocytes

Maria Diamandis1*, Andrew D Paterson, PhD2*, Johanna M Rommens, PhD2*, D. Kika Veljkovic, MD1*, Jessica Blavignac1*, John S Waye, PhD1*, Francine Derome3*, Georges E. Rivard, MD3 and Catherine PM Hayward, MD, PhD1

1McMaster University, Hamilton, ON, Canada
2The Hospital for Sick Children and The University of Toronto, Toronto, ON, Canada
3Centre Hospitalier Universitaire Sainte Justine, Montreal, QC, Canada